Skip to content
Temoporfin
Foscan (temoporfin) is a small molecule pharmaceutical. Temoporfin was first approved as Foscan on 2001-10-24. It has been approved in Europe to treat head and neck neoplasms and squamous cell carcinoma.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L01: Antineoplastic agents
L01X: Other antineoplastic agents in atc
L01XD: Sensitizers used in photodynamic/radiation therapy
L01XD05: Temoporfin
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8011
CholangiocarcinomaD018281C22.111
Klatskin tumorD018285EFO_100100511
Squamous cell carcinoma of head and neckD00007719511
Nasopharyngeal neoplasmsD00930311
Head and neck neoplasmsD00625811
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD00228922
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Squamous cell carcinomaD00229411
Tongue neoplasmsD014062EFO_0003871C02.911
Verrucous carcinomaD01828911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTEMOPORFIN
INNtemoporfin
Description
Temoporfin is a member of chlorins. It has a role as a photosensitizing agent.
Classification
Small molecule
Drug classbenzoporphyrin derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc2CC4)C=C3)c1
Identifiers
PDB
CAS-ID122341-38-2
RxCUI115243
ChEMBL IDCHEMBL383675
ChEBI ID
PubChem CID60751
DrugBankDB11630
UNII IDFU21S769PF (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,046 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,922 adverse events reported
View more details